Sun.Mar 24, 2024

article thumbnail

Beyond Steel Tanks

Codon

Elliot Hershberg and Niko McCarty write about the future of biomanufacturing for Issue 02. Read this essay on our website. Novo Nordisk and Eli Lilly have struck gold. After decades of research, their GLP-1 obesity drugs appear to really work. Globally, at least 1.9 billion people are overweight, and J.P. Morgan estimates that—in the U.S. alone—about 30 million people will soon be taking weight loss drugs: Wegovy from Novo Nordisk and ZepBound from Eli Lilly.

article thumbnail

2 in 3 parents say their adolescent or teen worries about how sick days may impact grades

SCIENMAG: Medicine & Health

ANN ARBOR, Mich. – Many parents struggle deciding whether their middle or high school aged child should stay home from school if they don’t feel well, a new national poll suggests. Credit: Sara Schultz, University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health ANN ARBOR, Mich.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Arkansas Law Prohibiting Manufacturer 340B Contract Pharmacy Restrictions Upheld by 8th Circuit

FDA Law Blog: Biosimilars

By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. The 340B contract pharmacy dispute involves several manufacturers who are refusing to provide 340B discounts to covered entities if they requested 340B drugs to be delivered to, and dispensed from, a network of contract p

article thumbnail

Researchers carry out first peer-reviewed study of fecal microbiota transplants in dolphins

SCIENMAG: Medicine & Health

Scientists have successfully carried out pioneering fecal microbiota transplantations on Navy bottlenose dolphins that showed signs of gastrointestinal disease. Credit: U.S.Navy Scientists have successfully carried out pioneering fecal microbiota transplantations on Navy bottlenose dolphins that showed signs of gastrointestinal disease.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Which drugs have supplementary protection certificates in the most countries?

Drug Patent Watch

This chart shows the drugs with the most supplementary protection certificates (SPCs).

Drugs 52